IL141801A0 - Methods and compositions for increasing intestinal absorption of fats - Google Patents

Methods and compositions for increasing intestinal absorption of fats

Info

Publication number
IL141801A0
IL141801A0 IL14180199A IL14180199A IL141801A0 IL 141801 A0 IL141801 A0 IL 141801A0 IL 14180199 A IL14180199 A IL 14180199A IL 14180199 A IL14180199 A IL 14180199A IL 141801 A0 IL141801 A0 IL 141801A0
Authority
IL
Israel
Prior art keywords
fats
compositions
methods
intestinal absorption
increasing intestinal
Prior art date
Application number
IL14180199A
Other languages
English (en)
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of IL141801A0 publication Critical patent/IL141801A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14180199A 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats IL141801A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (1)

Publication Number Publication Date
IL141801A0 true IL141801A0 (en) 2002-03-10

Family

ID=22274976

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14180199A IL141801A0 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats
IL141801A IL141801A (en) 1998-09-08 2001-03-04 Methods and compositions for increasing intestinal absorption of fats

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141801A IL141801A (en) 1998-09-08 2001-03-04 Methods and compositions for increasing intestinal absorption of fats

Country Status (13)

Country Link
US (1) US6426069B1 (ja)
EP (1) EP1119360B1 (ja)
JP (1) JP4700193B2 (ja)
CN (1) CN1321089A (ja)
AT (1) ATE347371T1 (ja)
AU (1) AU771901B2 (ja)
CA (1) CA2343116C (ja)
DE (1) DE69934325T2 (ja)
IL (2) IL141801A0 (ja)
NO (1) NO20011173L (ja)
NZ (1) NZ510536A (ja)
WO (1) WO2000013689A1 (ja)
ZA (1) ZA200102268B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407779B2 (en) * 2001-10-11 2008-08-05 Biomolecular Products, Inc. Modification of solid 3-sn-phosphoglycerides
EP1350435B1 (en) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
DK1594544T3 (en) * 2003-01-31 2016-07-25 Los Angeles Childrens Hospital ORAL COMPOSITIONS OF FENRETINIDE WHICH HAVE INCREASED BIOTAILABILITY AND PROCEDURES FOR USING IT
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
US10463229B2 (en) * 2010-10-22 2019-11-05 Fukuoka University Endoscopic observation method and composition for improving diagnostic performance involving applying useful white opaque substance to diagnosis of gastric epithelial tumors (adenoma or gastric cancer)
WO2012068169A2 (en) * 2010-11-15 2012-05-24 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
AU2019342421A1 (en) * 2018-09-21 2021-02-18 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
AU666293B2 (en) 1990-08-13 1996-02-08 David W. Yesair Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
ES2159740T3 (es) * 1995-06-06 2001-10-16 Biomolecular Products Inc Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
AU741943B2 (en) * 1996-09-11 2001-12-13 Elizabeth Shanahan-Prendergast Therapeutic formulations containing venom or venom anti-serum either lone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
DE69934325T2 (de) 2007-07-05
WO2000013689A1 (en) 2000-03-16
CA2343116C (en) 2008-11-18
JP4700193B2 (ja) 2011-06-15
AU5705299A (en) 2000-03-27
EP1119360B1 (en) 2006-12-06
JP2002524417A (ja) 2002-08-06
EP1119360A1 (en) 2001-08-01
DE69934325D1 (de) 2007-01-18
ZA200102268B (en) 2001-09-19
CA2343116A1 (en) 2000-03-16
US6426069B1 (en) 2002-07-30
ATE347371T1 (de) 2006-12-15
NZ510536A (en) 2003-07-25
NO20011173D0 (no) 2001-03-07
EP1119360A4 (en) 2003-06-04
IL141801A (en) 2009-02-11
CN1321089A (zh) 2001-11-07
AU771901B2 (en) 2004-04-08
NO20011173L (no) 2001-05-08

Similar Documents

Publication Publication Date Title
MXPA03008823A (es) Metodos, compuestos y composiciones para reducir la grasa corporal y modular el metabolismo de los acidos grasos.
IL141801A0 (en) Methods and compositions for increasing intestinal absorption of fats
BR9809793A (pt) Monoésteres de probucol para o tratamento de doença inflamatória e cardiovascular
WO1999058555A3 (en) Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
EP1710296A4 (en) LIPIDIC COMPOSITION CONTAINING A PHOSPHOLIPID AND A COMPOUND SUPPLYING LONG-CHAIN POLYUNSATURATED FATTY ACIDS, AND FOOD CONTAINING THE SAME
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
AU2002359949A1 (en) Compositions for improving lipid metabolism
WO2005046580A3 (en) Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
NO20024722D0 (no) Stivelses-subtyper og lipid metabolisme
BRPI0309421B8 (pt) método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
WO2002031202A3 (en) High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds
DE69628489D1 (de) Verfahren zur Herstellung von RTV-Einkomponenten-Siliconelastomerzusammensetzungen
AU6240099A (en) Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase A2
MXPA03002068A (es) Compuestos y formulaciones pro-nutrientes de ester de creatina.
GB0012229D0 (en) Lipid uptake assays
EP1461068A4 (en) METHOD AND COMPOSITIONS FOR NORMALIZING LIPID MIRRORS IN MIRACLE TISSUE
WO2004006731A3 (de) Bilderrahmen
IT1293067B1 (it) Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
FR2753200B1 (fr) Procede d'extraction de lipides provenant de la lecithine de soja, extrait lipidique obtenu et compositions dermato-cosmetiques le contenant
AU2001294245A1 (en) Compositions for improving lipid metabolism
WO2006068485A3 (en) Temporally meal menu for infants
WO2000027429A3 (en) Vaccine against papillomatous digital dermatitis (pdd)
WO2004111073A3 (fr) Procede de recuperation de sterols
TW200514775A (en) Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
ES8602410A1 (es) Un metodo de produccion de una composicion de aclarrubicina o hidrocloruro de aclarrubicina

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed